Live Quote · NASDAQCLDXHealthcare· Biotechnology

Celldex Therapeutics, Inc.

$27.42▼ 1.93%($-0.54)
MKT CAP $2.15BNEXT EARNINGS Feb 24, 2027
50%
Bullish
TickerSpark Score
39/100
▌ Weak
60
Valuation
20
Profitability
10
Growth
76
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLDX research report →

Analyst Price Target
$66.80+143.6% vs. today

Range $45 – $100

Analyst RatingBuy
17 Buy3 Hold0 Sell

Price Chart

+12.20% · this period
$44.87$33.72$22.58Nov 19May 22Nov 19
52-Week Range22% of range
Low
$22.33
Current
$27.42
High
$45.14